



Pharmacies in New York State can opt-in to a pharmacy based syringe access program called the Expanded Syringe 
Access Program (ESAP). Washington Heights CORNER Project, a syringe exchange program in New York City, 
undertook a two-part survey of pharmacies located less than two miles from the program in Northern Manhattan. 
The study sought to determine whether pharmacies registered for the Expanded Syringe Access Program were a 
reliable source of syringes for populations who purchase syringes without a prescription, including people who 
inject drugs. The surveys found that 71.4% of pharmacies listed on the ESAP directory sold syringes to a 
Washington Heights CORNER Project participant acting as a secret shopper. A follow up survey assessed 
pharmacy attitudes toward the program and other harm reduction measures. In this survey, pharmacies 
demonstrated interest in harm reduction measures, with 92% of pharmacies reporting willingness to refer 
potential customers to a local syringe exchange program. The researchers make recommendations for 
improvement to pharmacy-based syringe access programs at the individual, community and policy level, including 
increasing face to face interactions between syringe exchange programs and pharmacies and requiring regular 
updates to the online directory of ESAP-registered pharmacies. 
Background 
Washington Heights CORNER Project (WHCP) is a 
New York City-based state-waivered syringe exchange 
program (SEP) located at 566 W 181st Street. WHCP’s 
mission is to significantly improve the health and 
quality of life for people who use drugs and expands 
access to clean syringes through street-based outreach 
throughout Northern Manhattan. In 2014, WHCP 
undertook a two-part survey of pharmacies in 
Northern Manhattan. The first aim of the surveys was 
to determine whether pharmacies served as a source 
of syringes for customers without a prescription. The 
researchers’ primary focus was to improve access for 
syringe customers from WHCP, who primarily are 
people who inject drugs.  The second aim of the 
project was to identify ways to make pharmacies 
better resources for syringe customers at both the 
policy and grassroots levels. By strengthening ties with 
SEPs, improving harm reduction policies, and 
educating syringe customers about resources, 
including substance abuse treatment, pharmacies can 
align themselves with the mission of reducing 
transmission of blood-borne disease. 
Importance of Harm Reduction in New 
York State 
Improving access to steri le syringes is an 
internationally recognized strategy for reducing risks 
associated with injection equipment sharing. Syringe 
access measures are situated in the context of harm 
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reduction, a human rights movement that 
understands drug use as a complex spectrum and calls 
for nonjudgmental and non-coercive treatment of 
users of illicit drugs.  Harm reduction principles are 1
applied through evidence-based interventions, 
ranging from the implementation of motivational 
interviewing techniques to providing access to 
supervised injection sites or safer consumption rooms, 
as in Vancouver.  Such interventions aim to, and have 2
in various instances, been noted to reduce the 
incidence of sharing injection equipment, the 
presence of discarded syringes in public areas, and of 
transmission of blood-borne infection such as HIV 
and Hepatitis C (HCV).2 Both New York’s SEP and 
Expanded Syringe Access Program (ESAP) laws derive 
from harm reduction principles. 
The importance of clean syringes in preventing the 
spread of blood-borne diseases like HIV and HCV 
cannot be overstated. Although new diagnoses are 
declining, New York City continues to have one of the 
highest rates of HIV prevalence in the United States 
and an increasing number of people living with HIV 
(PLHIV).  As of 2012, people who inject drugs 3
account for at least 4.4% of HIV diagnoses in New 
York City, and account for 17.0% of PLHIV, and 36.6% 
of related deaths.3 The availability of sterile syringes, 
even at cost, has played a tremendous role in the 
reduction of this number, mirroring the results 
achieved in other harm reduction settings. 
Development and preliminary 
evaluations of ESAP in New York State  
ESAP authorizes licensed pharmacies, health care 
facilities and health care practitioners to furnish, at a 
price set by the provider, up to 10 hypodermic 
needles/syringes without prescription to people 18 
years of age or older.  The program was piloted in 4
2001 and became permanent in 2009.4 The stated 
purpose of the program is to prevent transmission of 
blood-borne diseases, primarily HIV, hepatitis B, and 
HCV.4 Pharmacies are an important resource for 
people who inject drugs because they offer syringes at 
times that SEPs may be closed, such as weekend hours 
and evenings , and offer 
services to customers who may 
not know of an SEP in their 
area or feel comfortable going 
to an SEP. Studies have shown 
that people who inject drugs 
will not walk more than ten 
minutes to obtain a syringe,  5
so pharmacies also provide 
enhanced geographical access 
for syringe distribution and 
other harm reduction services. 
Pharmacies are not currently 
allowed to advertise their ability 
to sell syringes behind the counter,4 but may 
demonstrate their participation in ESAP by displaying 
an ESAP sticker on their window. 
  
ESAP allows enrolled pharmacies to use their 
discretion when selling syringes and does not prohibit 
providers from refusing sale. A survey of 62 ESAP 
customers in 2009 found that 53% of ESAP customers 
surveyed had been refused at some point when trying 
to purchase a nonprescription syringe at an enrolled 
pharmacy.  This finding was associated with both race 6
and gender, but further reasons for turning away 
medicalreview.columbia.edu Col Med Rev 1(1);40-50 25 May 2015
Artwork by Hannah Singer
COLUMBIA MEDICAL REVIEW
customers seeking nonprescription syringes were not 
explored. Experiencing refusal when trying to 
participate in a legal program like ESAP may 
discourage syringe customers from participation in 
programs to obtain clean syringes in the future. 
  
The ESAP program has demonstrated great success by 
gaining large numbers of registered pharmacies and 
improving awareness of available syringes. By August 
2002, there were over 2,000 ESAP-registered 
providers.  Of all registered providers, 98% were 7
pharmacies, representing 62% of all eligible 
pharmacies in New York State.7 A 2003 survey of 
ESAP-registered pharmacies found that on average, 
pharmacies reported 22 ESAP customers per month.  8
By comparison, WHCP typically fulfills over 600 
syringe transactions per month. 
  
In New York State, pharmacies and health care 
facilities or practitioners must register with the New 
York State Department of Health to participate in the 
ESAP program, but the process has been made 
purposefully simple and free of charge to encourage 
registration.4 The New York State Department of 
Health maintains an online directory of participants, 
who are required to alert the New York State 
Department of Health if they withdraw from the 
program.4 The last known update of this directory was 
July 31st, 2012.  Previous evaluations of ESAP have 9
been conducted by the government in 2003,7 the New 
York State AIDS Advisory Council,  and others.6 The 10
following study should not be assumed to be an 
evaluation of the ESAP program, and a thorough 
evaluation of ESAP should be conducted. 
  
The Secret Shopper Survey 
The initial phase of the study, the Secret Shopper 
Survey, sought to identify pharmacies willing to sell to 
syringe customers, and determine whether 
pharmacies are a reliable source of syringes for syringe 
customers in Northern Manhattan. The researchers 
hypothesized that some ESAP-registered pharmacies 
would refuse to sell to the secret shopper and that the 
Directory of ESAP-registered pharmacies available 
online was outdated. 
  
A secret shopper system was used to ascertain 
whether neighborhood pharmacies would sell 
syringes to syringe customers with the characteristics 
of typical WHCP program participants. A survey tool 
used on previous WHCP secret shopper assessments 
already existed, and minor alterations to this survey 
were made for its use in this project. The survey is 
attached here as Appendix 1. 
  
A list of ESAP-registered pharmacies in Northern 
Manhattan was gathered from the Directory of ESAP 
Providers in New York State.9 According to this list, 
there were 35 ESAP-registered pharmacies in the five 
zip codes of Northern Manhattan (10031, 10032, 
10033, 10040, 10034). To locate pharmacies not on the 
ESAP Directory in the area, a search was conducted 
on both Google Maps and YellowPages.com. A final 
list was compiled from these searches and an 
additional 56 pharmacies not on the ESAP Directory 
were located. 
  
Northern Manhattan was divided into sections, and 
each section was surveyed street-by-street on foot by a 
team of WHCP volunteers partnered with WHCP 
participants acting as secret shoppers. All pharmacies 
on the map were visited, and any additional 
pharmacies discovered were added to the map. A total 
of 91 pharmacies were surveyed between January and 
June 2014. Four WHCP volunteers and 13 WHCP 
participants participated in the Secret Shopper Survey 
to determine whether the pharmacies were willing to 
sell syringes. WHCP provided round trip subway fare 
and a $5 gift card for secret shoppers. WHCP 
participants were made aware of the opportunity 
through announcements in the drop in center. 
  
The Attitude Survey 
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The second, or follow-up phase of the study, 
implemented an Attitude Survey to assess attitudes of 
pharmacies in Northern Manhattan toward syringe 
customers and ESAP itself to explore possibilities for 
program improvement through grassroots and policy 
approaches. The researchers hypothesized that 
pharmacy staff would have limited knowledge of harm 
reduction and mixed attitudes toward ESAP. 
  
WHCP volunteers administered the Attitude Survey 
alone. An initial version of the survey tool was tested 
on 19 pharmacies in zip codes 10040 and 10034 in 
March 2014. Improvements were made to the tool, 
and questions from previous surveys published by 
Coffin, et al. in 2000  and another published by Klein, 11
et al., in 2001  were incorporated into the final tool. 12
This second tool was used for the remainder of the 
surveys in May and June 2014. Tools were prepared 
for pharmacies that sold to the secret shopper 
(Appendix 2) and for pharmacies that did not sell to 
the secret shopper (Appendix 3). 
  
Attitude Surveys were conducted in 67 of the 91 
pharmacies surveyed during the initial Secret Shopper 
phase of the project. 19 of these follow-up surveys 
were conducted using the original version, and 49 
with the updated version. Five pharmacies refused to 
participate in the follow-up surveys. The other 18 
unsurveyed pharmacies were busy or closed when 
revisited for follow-up. Not all pharmacies provided a 
response to each question. 
  
Following procedures used in a previous survey of 
pharmacies in New York City,8 when conducting the 
Attitude Survey, the interviewer asked to speak to the 
pharmacist, briefly explained the purpose and 
confidentiality of the survey and requested consent. 
  
In consultation with the IRB at Columbia Mailman 
School of Public Health, it was established that IRB 
approval was not necessary for either of the phases of 
this project, as the researchers would be collecting 
information about pharmacies but not individuals. 
Researchers did not collect personal information 
about pharmacists during the surveys. 
Figure 1 presents the number of pharmacies visited 
during each survey, stratified by ESAP participation, 
whether the pharmacy sold to the secret shopper, zip 
code and corporate status. Figure 2 compares 
demographic information for each zip code  13
surveyed compared to the WHCP population.  14
Strengths and Limitations of 
Methodology 
Secret shoppers were WHCP participants of various 
physical appearances and racial backgrounds and 
gender presentation. Secret shoppers were not 
instructed on engagement strategies beyond task 
instruction. This is both a strength and a limitation of 
the methodology, as it created a representative sample 
of WHCP participants but limits our ability to 
generalize to other populations. Although every 
pharmacy was visited during the Secret Shopper 
Survey, not every pharmacy was willing to participate 
in the follow up Attitude Survey, limiting our sample 
size and ability to draw conclusions. Sample size was 
further limited by the changes made to the Attitude 
Survey midway through the implementation.  
Results 
Data analysis was conducted in Stata v 13.1 using 
Pearson chi-square and linear regression analysis 
(StataCorp. 2013. Stata Statistical Software: Release 13. 
College Station, TX: StataCorp LP). 
  
Of the 35 pharmacies listed on the ESAP Directory 
located in Northern Manhattan, 25 sold syringes to 
the secret shopper (71.4%). An additional 10 
pharmacies not listed on the Directory sold to the 
secret shopper. Each of these 10 pharmacies claimed 
to be ESAP-enrolled. Out of 91 total Northern 
Manhattan pharmacies, 35 pharmacies (38.5%) sold 
syringes over the counter to the secret shopper. 
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When asked whether they would be willing to sell 
syringes without prescription to a customer claiming 
to be diabetic, 44 out of 49 pharmacies (90%) said 
they would be willing to sell. When pharmacists were 
asked if they would be willing to sell to someone 
“claiming to be diabetic who looked like a drug user,” 
this number decreased to 29 out of 49 (59%), 
demonstrating how critical a factor physical 
appearance can be. Both of these attitudes were 
associated with selling to the secret shopper (p=0.026, 
p=0.011, respectively), but were not significantly 
different from each other (p=0.357), potentially due to 
the small sample size of this study. 
  
Awareness of ESAP is high among pharmacies in 
Northern Manhattan, with 44 of the 49 pharmacies 
surveyed during Attitude Survey phase (90%) having 
heard of the program. A majority of the pharmacies 
surveyed during the Attitude Survey, 40 out of 49 
(82%) agreed with ESAP’s goal “that members of your 
community, including drug users, should be able to 
obtain syringes over the counter from pharmacies in 
order to prevent disease transmission.” Agreement 
with this goal was strongly associated with selling to 
the secret shopper (p=0.002). 
  
Compared to familiarity with ESAP, upon initial 
contact during the Secret Shopper Survey fewer 
pharmacies knew what a Syringe Exchange Program 
was (48%), and 5% of the pharmacies surveyed had 
heard of Washington Heights CORNER Project, the 
nearest geographical SEP. Knowledge of an SEP was 
not associated with willingness to sell to the secret 
shopper (p=0.276). During the Attitude Survey, the 
number of pharmacies reporting that they had heard 
of WHCP increased to 23 out of 48 (48%). 
  
Only 15 of the 87 pharmacies displayed the optional 
ESAP sticker in their window (17%). The presence of a 
sticker was strongly associated with a pharmacy 
selling to the secret shopper (p<0.001) but was not a 
guarantee that a sale would occur. Two of the 10 
pharmacies that were on the ESAP Directory but did 
not sell to the secret shopper had an ESAP sticker in 
their window. The majority of pharmacies (76%) said 
they would not be willing to advertise ESAP services, 
whether they sold to the secret shopper or not. 
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Figure 1. Characteristics of pharmacies surveyed over the course of both surveys. Secret shopper surveys show 
the number of pharmacies, stratified by ESAP directory status, that sold to secret shoppers. The attitude survey 
shows the number of pharmacies that provided responses to the survey. A total of 91 pharmacies across 5 zip 
codes were studied.
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Willingness to advertise ESAP services was not 
associated with selling to the secret shopper 
(p=0.666). 
Pharmacies that sold to the secret shopper 
were asked during follow up with the Attitude 
Survey if a list of factors influenced their 
willingness to sell syringes to a given customer. 
Factors included possible influences used in a 
previous survey published by Coffin, et al. in 
2000.11 Results are presented in Figure 3. 
During the Attitude Survey, unregistered 
pharmacies were asked why they had chosen 
not to register. Results are presented in Table 1. 
Type, Number and Price of 
Syringes Sold 
Of the 35 pharmacies that sold syringes to the secret 
shopper, 27 sold syringes one at a time (77%). The 
price of a single syringe in Northern Manhattan 
ranged from $0.29 to $1. The pharmacies selling 
syringes at $0.29 (n=2) sold an average of 50 syringes 
per month, while the pharmacies selling syringes at $1 
(n=13) sold an average of 16.8 syringes per month. 
However, the relationship between cost of a single 
syringe and number of syringes sold per month was 
not found to be statistically significant following a 
linear regression analysis (p=0.134). Syringes were 
sold in packs of 10 by 31 of the 35 pharmacies that 
sold syringes to the secret shopper (89%) in Northern 
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Figure 2. Demographics of WHCP and surrounding neighborhoods. Gender and racial demographics are given 
for the 5 zip codes studied.
Figure 3. Factors that influence “willingness to sell” syringe to 
a given customer. All percentages out of n=25 respondents.
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Manhattan, ranging in price from $2.90 to $10. The 
pharmacy selling packs of ten syringes at $2.90 (n=1) 
sold 50 syringes a month. The pharmacies selling 
packs of ten syringes at $10.00 (n=8) sold an average 
of sixteen syringes per month. Again, the relationship 
between price of a pack of syringes and number of 
syringes sold per month was not found to be 
statistically significant following a linear regression 
analysis (p=0.07). The average number of syringes 
sold per month was 100.5, with one outlier of 2000 
syringes per month, replaced by the mean for linear 
regression analyses.  
Pharmacies in Northern Manhattan estimated that 
they sold a total of 3922 syringes each month, 
including the outlier.  By comparison, WHCP, serving 
the same geographical area between January and June 
2014, distributed an average of 6873 syringes per 
month. It is clear that, while pharmacies are being 
utilized, a greater need exists in this community. 
Increasing the number of pharmacies registered for 
ESAP would expand geographical access to syringes. 
Information on available syringes by gauge and 
volume as reported by pharmacies are presented in 
Figures 4 and 5. 
  
Interest in Further Public Health 
Initiatives 
Informed by a study conducted by Coffin, et al.,11 
researchers included questions assessing pharmacies’ 
interest in implementing other public health 
initiatives. 
• 86% of pharmacies (42/49) said they would 
distribute free sharps disposal containers. 
• 94% of pharmacies (45/48) said they would 
distribute pamphlets on safer sex. 
• 0% of pharmacies (44/49) said they would distribute 
pamphlets on safer intravenous drug use. 
• 92% of pharmacies (45/49) said they would provide 
referrals to syringe exchange programs. 
• 92% of pharmacies (45/49) said they would make 
referrals to substance abuse treatment programs. 
Recommendations 
The findings of the surveys have allowed the 
researchers to develop recommendations to improve 
ESAP and pharmacy-based syringe access. These 
recommendations include interventions at the 
individual, community and policy level. 
  
Individual Level 
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Table 1. Reasons pharmacies provided for not 
registering for ESAP.
Figures 4 and 5. Syringes available at pharmacies by CC 
size and gauge, respectively.
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Researchers hypothesized that pharmacies would have 
limited knowledge of harm reduction and that 
pharmacies would have mixed attitudes toward ESAP. 
Despite low participation levels in ESAP in Northern 
Manhattan (38.5%), most pharmacies had heard of the 
program (90%) and even agreed with the program 
goals (82%). Knowledge of other harm reduction 
measures was low. Just under 50% of pharmacies 
knew what an SEP was, and 5% of the pharmacies 
surveyed had heard of WHCP during the first phase 
of the study. If pharmacies were given a more 
comprehensive education on harm reduction policies 
and made better aware of SEPs, they would better 
understand their role in harm reduction. 
  
Pharmacy education should seek to increase the 
number of “supportive pharmacies” in a community. 
The researchers define supportive pharmacies as those 
pharmacies that are willing to enroll in ESAP 
program, sell to people who inject drugs, and 
participate in a referrals program to drug treatment 
and/or syringe exchange. Pharmacy education would 
be most effective if personalized to the individual 
pharmacy level, so phone calls and canvassing should 
be used whenever possible. The burden of pharmacy 
education should not fall to New York State 
Department of Health. SEPs should seek to strengthen 
ties with the pharmacies in the neighborhoods they 
serve. During Attitude Survey 50% of pharmacies had 
heard of WHCP, demonstrating that face-to-face 
outreach can be successful in raising awareness about 
nearby SEPs. Other SEPs should coordinate with 
individual pharmacies nearby to inform them of 
neighborhood syringe customers-preferred syringes to 
ensure they are kept in stock. SEPs can also provide 
education about harm reduction on the individual 
level to pharmacists and pharmacy staff. This may also 
pave the way for implementation of further harm 
reduction measures, such as naloxone or overdose 
prevention programs. These programs will soon be 
made possible in New York by the recent passage of a 
New York State standing order prescription 
authorizing pharmacies to train and distribute 
naloxone as necessary to customers fi l l ing 
prescriptions for opioid analgesics.  15
  
Community Level 
The researchers were interested in the types of 
syringes available in Northern Manhattan pharmacies. 
The information gathered indicates disconnect 
between pharmacies and populations of syringe 
customers, especially people who inject drugs. In 
pharmacies, the most commonly available syringes 
were 28 and 29 gauges. By contrast, WHCP distributes 
27 gauge syringes about 90% of the time. Pharmacies 
purchase their syringes based on the most commonly 
prescribed varieties, which are usually for 
administration of insulin and other medications. 
Therefore the syringes preferred by people who inject 
drugs may not be kept in stock. Injection norms 
become instituted in populations of people who inject 
drugs over time.  If syringe customers could access 16
the preferred type of syringe from a pharmacy, they 
may be more likely to be a customer. If the syringe of 
choice is not kept in stock, word-of-mouth may act as 
a deterrent to other syringe customers within the 
community of people who inject drugs. 
  
Previous evaluations of ESAP have also suggested 
increased increased outreach and collaboration 
between pharmacies and community-based coalitions.
6,7,10 Several steps can be taken to strengthen 
relationships on the community level. WHCP has 
provided neighboring pharmacies with materials 
developed specifically for customers who may not 
know that access to free syringes exists at SEPs. 
WHCP also makes “Friendly Pharmacy” lists available 
to participants who are likely to be syringe customers 
at neighborhood pharmacies. Pharmacies surveyed 
expressed interest in other public health initiatives. 
Over 85% of pharmacies indicated they would 
distribute free sharps disposal containers and 
pamphlets on safer intravenous drug use if these were 
made available to them and over 90% of pharmacies 
indicating they would distribute pamphlets on safer 
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sex and provide referrals to syringe exchange 
programs and/or substance abuse treatment 
programs. Each of these harm reduction interventions 
could be implemented in pharmacy settings and used 
to deepen relationships between pharmacies, the New 
York State Department of Health and SEPs. 
  
Policy Level 
Researchers hypothesized that some ESAP-registered 
pharmacies would refuse to sell to the secret shopper 
and that the Directory of ESAP-registered pharmacies 
available online was outdated. Only 71.4% of 
pharmacies listed on the ESAP Directory sold syringes 
to the secret shopper, and 10 pharmacies not listed on 
the Directory sold to the secret shopper but claimed 
ESAP-enrollment. The ESAP Directory has not been 
kept up to date. Of 26 registered pharmacies surveyed, 
6 (23%) reported being contacted by the New York 
State Department of Health within the past year about 
ESAP. Pharmacies may not be aware that they are 
required to update New York State Department of 
Health if they have opted out of the program. 
Pharmacies may also have relocated since the last 
publication of the Directory in 2012. Previous 
evaluations have focused policy recommendations on 
encouraging the lifting of the restriction on pharmacy 
advertising,6,7,10 but our findings suggest this emphasis 
is misplaced, with the majority of pharmacies (76%) 
stating they would not be willing to advertise ESAP 
services, whether they sold to the secret shopper or 
not.  
  
Policy level interventions could include abandoning 
the ESAP program altogether in favor of legislation 
allowing all pharmacies to sell syringes to customers 
without a prescription as many states across the US 
have.  This would remove confusion among 17
pharmacists of the legality of selling syringes and 
expand geographical access to syringes for syringe 
customers. If this were not feasible, possible 
improvements could include increasing the number of 
syringes sold per transaction with syringe customers, 
from 10 to unlimited. Finally, the New York State 
Department of Health should conduct routine check-
ups on participating pharmacies to ensure adherence 
to the program and an up-to-date registry. 
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